Equipment and methodolgies for non-invasive treatment for addiction

US11357997B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11357997-B2
Application numberUS-201816120974-A
CountryUS
Kind codeB2
Filing dateSep 4, 2018
Priority dateSep 1, 2017
Publication dateJun 14, 2022
Grant dateJun 14, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methodologies and mechanisms are provided for introducing one or more magnetizable particles introduced non-invasively into one or more body structures containing nervous tissue in a subject, directing, guiding, transporting, focusing and/or concentrating the one or more particles using at least one image-guidance component in proximity to the one or more body structures which can direct the one or more particles within the one or more body structures, and modulating, using at least one activation component, the one or more particles to modulate neuronal function in the one or more body structures of the subject.

First claim

Opening claim text (preview).

What is claimed: 1. A method of treating a patient with a neurological disorder with noninvasive administration of one or more magnetizable particles, wherein the method comprises: performing image-guided magnetic delivery of the one or more magnetizable particles to a neural structure of a subject; and modulating the neural structure with at least one activation component so as to treat the neurological disorder. 2. The method of claim 1 , wherein the neurological disorder is an addiction disorder. 3. The method of claim 1 , wherein the modulation is activated by an authorization code that is not known to the subject. 4. The method of claim 1 , wherein neuromodulation is implemented by moving the one or more magnetizable particles in the neural structure. 5. The method of claim 1 , wherein the one or more magnetizable particles degrade in less than one month. 6. The method of claim 1 , wherein the one or more magnetizable particles degrade in less than one year. 7. The method of claim 1 , wherein the at least one activation component weighs less than 10 kilograms. 8. The method of claim 1 , wherein the image-guided magnetic delivery of the one or more magnetizable particles to the subject's neural structure is performed using at least one image-guidance component positioned in proximity to the neural structure within the subject, wherein the at least one image-guidance component is configured to direct the one or more magnetizable particles within the one or more body structures. 9. The method of claim 8 , wherein the at least one image-guidance component comprises an MRI system that includes at least one magnetic coil. 10. The method of claim 8 , wherein the MRI system is a single-sided MRI system. 11. The method of claim 8 , wherein the MRI system includes a plurality of electropermanent sections. 12. The method of claim 8 , wherein the MRI system generates pulse sequences wherein the MRI has pulse sequences whose rise-time, fall-time, or duration are less than 10 microseconds long. 13. The method of claim 8 , wherein the MRI system includes at least one magnetic coil generates a magnetic field that rises or falls in such short a time as not to cause nerve stimulation of the subject. 14. The method of claim 13 , wherein the at least one magnetic coil generates a magnetic field that rises or falls in less than 10 microseconds.

Assignees

Inventors

Classifications

  • by the tactile sense, e.g. vibrations · CPC title

  • Magnet assemblies for single-sided MR wherein the magnet assembly is located on one side of a subject only; Magnet assemblies for inside-out MR, e.g. for MR in a borehole or in a blood vessel, or magnet assemblies for fringe-field MR · CPC title

  • A61N2/006Primary

    for magnetic stimulation of nerve tissue · CPC title

  • Manipulators for magnetic surgery · CPC title

  • Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11357997B2 cover?
Methodologies and mechanisms are provided for introducing one or more magnetizable particles introduced non-invasively into one or more body structures containing nervous tissue in a subject, directing, guiding, transporting, focusing and/or concentrating the one or more particles using at least one image-guidance component in proximity to the one or more body structures which can direct the on…
Who is the assignee on this patent?
Weinberg Medical Physics Inc
What technology area does this patent fall under?
Primary CPC classification A61N2/006. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).